Loading...

APC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APC_090507
C57BL/6 mouse splenocytes stained with 30-F11 APC
  • 30-F11_APC_090507
    C57BL/6 mouse splenocytes stained with 30-F11 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
103111 25 µg £23
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103112 100 µg £65
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Witherel CE, et al. 2021. Biomaterials. 269:120667. PubMed
  2. Kozuki S, et al. 2022. Genes Cells. 27:192. PubMed
  3. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  4. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  5. Lloyd-Lewis B, et al. 2022. Cell Rep. 38:110461. PubMed
  6. Yang Y, et al. 2022. FEBS J. 289:5279. PubMed
  7. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  8. Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed
  9. Van Deren DA, et al. 2022. Development. 149: . PubMed
  10. Lee R, et al. 2022. Cancer Discov. 12:1702. PubMed
  11. Jiang W, et al. 2022. FASEB J. 36:e22294. PubMed
  12. Wang S, et al. 2022. Sci Adv. 8:eabn3883. PubMed
  13. Wu TJ, et al. 2022. Cell Mol Life Sci. 79:348. PubMed
  14. Malhi H, et al. 2022. Cell Rep Med. 3:100658. PubMed
  15. Campisi L, et al. 2022. Nature. 606:945. PubMed
  16. Ma Z, et al. 2022. Theranostics. 12:4965. PubMed
  17. Richards M, et al. 2022. Elife. 11: . PubMed
  18. Gao Y, et al. 2022. Cell Res. 32:1086. PubMed
  19. Ge Y, et al. 2022. iScience. 25:105437. PubMed
  20. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  21. Cattaneo P, et al. 2022. Nat Commun. 13:7444. PubMed
  22. Wang H, et al. 2022. J Nanobiotechnology. 20:513. PubMed
  23. Kuo CS, et al. 2022. Elife. 11: . PubMed
  24. Ge Y, et al. 2022. STAR Protoc. 4:101936. PubMed
  25. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  26. Urata S, et al. 2023. Microbiol Immunol. 67:105. PubMed
  27. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  28. Hu R, et al. 2023. Cell Death Discov. 9:50. PubMed
  29. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  30. Dragan M, et al. 2022. J Invest Dermatol. 142:583. PubMed
  31. Wei J, et al. 2022. Cancer Prev Res (Phila). 15:285. PubMed
  32. Yang Z, et al. 2022. J Nucl Med. 63:1708. PubMed
  33. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  34. Li DD, et al. 2022. Cell Host Microbe. 30:530. PubMed
  35. Bohrer AC, et al. 2022. Cell Rep. 40:111144. PubMed
  36. Yu L, et al. 2022. Cancer Sci. 113:3980. PubMed
  37. Kuo A, et al. 2022. Elife. 11:. PubMed
  38. Chen LC, et al. 2023. Immunology. 169:271. PubMed
  39. Wilson NG, et al. 2023. iScience. 26:105991. PubMed
  40. Peng YJ, et al. 2023. Development. 150:. PubMed
  41. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  42. Pioli KT, et al. 2023. iScience. 26:106223. PubMed
  43. Wu Y, et al. 2023. Nat Cancer. 4:382. PubMed
  44. Henn RE, et al. 2023. iScience. 26:106164. PubMed
  45. Barberio AE, et al. 2023. Bioeng Transl Med. 8:e10453. PubMed
  46. Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed
  47. Tan X, et al. 2023. Adv Sci (Weinh). 10:e2206768. PubMed
  48. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  49. Yao H, et al. 2023. Front Immunol. 14:1147674. PubMed
  50. Hernandez VG, et al. 2023. Glia. 71:1960. PubMed
  51. Liu H, et al. 2023. Breast Cancer Res. 25:43. PubMed
  52. Petenkova A, et al. 2023. Nat Commun. 14:2761. PubMed
  53. Abdelwahab T, et al. 2023. iScience. 26:106698. PubMed
  54. Shao X, et al. 2023. Cell Discov. 9:44. PubMed
  55. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  56. Kalgudde Gopal S, et al. 2023. Nat Commun. 14:3020. PubMed
  57. Li M, et al. 2023. BMC Cancer. 23:497. PubMed
  58. Nigam S, et al. 2020. Mol Imaging Biol. 22:685. PubMed
  59. Yang D, et al. 2022. Cell. 185:1905. PubMed
  60. Tan L, et al. 2022. Aging Dis. 13:1562. PubMed
  61. Gavin KM, et al. 2018. Front Endocrinol (Lausanne). 9:276. PubMed
  62. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  63. Cha JH et al. 2018. Molecular cell. 71(4):606-620 . PubMed
  64. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  65. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  66. Strickley JD, et al. 2019. Nature. 575:519. PubMed
  67. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  68. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  69. Shah D, et al. 2021. Oncoimmunology. 10:1939601. PubMed
  70. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  71. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  72. Almada AE, et al. 2021. Cell Reports. 34(4):108656. PubMed
  73. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  74. Garcia-Fabiani MB, et al. 2020. Methods Enzymol. 632:369. PubMed
  75. Jaiswal AK, et al. 2020. Immunobiology. 225:151956. PubMed
  76. Cayre S, et al. 2020. Development. 147:00:00. PubMed
  77. Díaz NM, et al. 2020. Invest Ophthalmol Vis Sci. 61:37:00. PubMed
  78. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  79. Oetjen LK et al. 2017. Cell. 171(1):217-228 . PubMed
  80. Testini C, et al. 2019. EMBO Rep. 20:e47845. PubMed
  81. Gao Q, et al. 2019. J Exp Med. 216:688. PubMed
  82. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  83. Wang Y, et al. 2021. J Bone Oncol. 30:100386. PubMed
  84. Lu L, et al. 2022. Sci Rep. 12:931. PubMed
  85. Parhiz H, et al. 2022. J Control Release. 344:50. PubMed
  86. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  87. Du Q, et al. 2019. Front Microbiol. 10:2050. PubMed
  88. Kang I, et al. 2012. Blood. 119:3295. PubMed
  89. Ahmed M, et al. 2016. Development. 143: 1663 - 1673. PubMed
  90. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  91. Lim JT, et al. 2020. Mol Cancer Ther. 1809:19. PubMed
  92. Rosa FF, et al. 2020. Bio Protoc. 10:e3619. PubMed
  93. Chen J, et al. 2022. Nat Commun. 13:6759. PubMed
  94. Wang S, et al. 2022. Front Immunol. 13:869061. PubMed
  95. Zhang Y, et al. 2022. Cancers (Basel). 14:. PubMed
  96. Barwe SP, et al. 2022. J Clin Med. 11:. PubMed
  97. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  98. Yu X, et al. 2021. Nature. 594:560. PubMed
  99. Sato S, et al. 2021. Int J Mol Sci. 22:. PubMed
  100. Oliva Chávez AS, et al. 2021. Nat Commun. 12:3696. PubMed
  101. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
  102. Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed
  103. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  104. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  105. Barberio AE, et al. 2020. ACS Nano. 14:11238. PubMed
  106. Chiche A, et al. 2016. Oncogene. 10.1038/onc.2016.396. PubMed
  107. Eastman A, et al. 2016. J Immunol . 194: 5999-6010. PubMed
  108. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
  109. Hays C, et al. 2020. eLife. 8:e48772.. PubMed
  110. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  111. Li Q, et al. 2021. Brain Behav Immun. 94:437. PubMed
  112. Wang X, et al. 2022. Nat Aging. 2:155. PubMed
  113. Wang T, et al. 2020. Blood Sci. 2:79. PubMed
  114. Jin X, et al. 2019. Mol Cell. 73:22:00. PubMed
  115. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  116. Strunz M, et al. 2020. Nat Commun. 2.929861111. PubMed
  117. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  118. Schiller M, et al. 2021. Immunity. 54(5):1022-1036.e8. PubMed
  119. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  120. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  121. Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed
  122. Motoyama S, et al. 2020. Cells. :9. PubMed
  123. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  124. Romagnoli M, et al. 2020. Development. 147:. PubMed
  125. Mauduit O, et al. 2022. Front Immunol. 13:1011125. PubMed
  126. Chen Z, et al. 2022. Theranostics. 12:6242. PubMed
  127. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  128. Bourn JR, et al. 2021. Cancer Lett. 503:75. PubMed
  129. Khateb M, et al. 2022. Cell Rep. 40:111219. PubMed
  130. Xu Q, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  131. Liu K, et al. 2022. Theranostics. 12:639. PubMed
  132. Sato Y, et al. 2021. J Clin Invest. Online ahead of print. PubMed
  133. Lv H, et al. 2020. Cell Metabolism. 33(1):110-127.e5. PubMed
  134. Amouyal C, et al. 2020. EBioMedicine. 58:102895. PubMed
  135. Liu L, et al. 2015. Neurol Neuroimmunol Neuroinflamm. 2: 174. PubMed
  136. Hyatt L, et al. 2014. PLoS One. 9:109072. PubMed
  137. Pelletier A, et al. 2012. J Immunol. 188:5561. PubMed
  138. Herting CJ, et al. 2019. Brain. 142:3834. PubMed
  139. Romagnoli M, et al. 2019. Stem Cell Reports. 1.077083333. PubMed
  140. Ning X, et al. 2019. Mol Cell. 74:19. PubMed
  141. De S, et al. 2018. Development. 145. PubMed
  142. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  143. An J,et al. 2017. Sci Rep.. 10.1038/s41598-017-13629-0. PubMed
  144. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  145. Maston LD, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L609. PubMed
  146. Bresson L, et al. 2018. Development. 145. PubMed
  147. Charmsaz S, et al. 2017. Leukemia. 31:1779. PubMed
  148. Sambasivan R, et al. 2011. Development. 138:3647. PubMed
  149. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  150. Ma S, et al. 2021. Cell Reports. 34(6):108726. PubMed
  151. Ankawa R, et al. 2021. Developmental Cell. . PubMed
  152. Hu EY, et al. 2021. Blood Adv. 5:3152. PubMed
  153. Palathingal Bava E, et al. 2022. JCI Insight. 7:. PubMed
  154. Fischer A, et al. 2022. Nat Immunol. 23:518. PubMed
  155. Hu J, et al. 2022. Cell Mol Neurobiol. . PubMed
  156. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  157. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  158. Wu J, et al. 2020. Immunity. 53:115. PubMed
  159. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  160. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  161. Kotfis K, et al. 2020. British Journal of Pharmacology. 49(1):66-72. PubMed
  162. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  163. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  164. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  165. Zheng B, et al. 2018. J Hematol Oncol. 11:16. PubMed
  166. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  167. Thinard R, et al. 2022. Pharmaceutics. 14:. PubMed
  168. Yang H, et al. 2022. Nutrients. 14:. PubMed
  169. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  170. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  171. Yuan Z, et al. 2018. Emerg Microbes Infect. 7:59. PubMed
  172. Hou M, et al. 2020. Stem Cell Res Ther. 11:55. PubMed
  173. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  174. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  175. Hanasoge Somasundara AV, et al. 2021. Cell Rep. 37:110099. PubMed
  176. Crooks SD, et al. 2022. Immunohorizons. 6:705. PubMed
  177. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  178. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  179. Koren E, et al. 2022. Nat Commun. 13:4628. PubMed
  180. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  181. Li P, et al. 2022. EMBO Mol Med. 14:e14511. PubMed
  182. Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
  183. Myerson JW, et al. 2021. Nat Nanotechnol. Online ahead of print. PubMed
  184. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  185. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  186. Dudek KA, et al. 2020. Proc Natl Acad Sci U S A. 117:3326. PubMed
  187. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  188. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  189. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  190. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  191. Kaur A, et al. 2019. Cancer Discov. 9:64. PubMed
  192. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  193. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  194. Wang C, et al. 2011. Hepatology. 55:108. PubMed
  195. Sim S, et al. 2016. PLoS One. 11: 0152485. PubMed
  196. Mangum L, et al. 2016. Toxicol Sci. 150: 169 - 177. PubMed
  197. Mizuno T, et al. 2017. Sci Rep. 7:42714. PubMed
  198. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  199. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  200. Shannon JP, et al. 2021. STAR Protoc. 2:100790. PubMed
  201. Yang Y, et al. 2022. Elife. 11:. PubMed
  202. Limbad C, et al. 2022. iScience. 25:103848. PubMed
  203. Chiang HY, et al. 2022. Nat Commun. 13:874. PubMed
  204. Aguilera M, et al. 2021. Int J Mol Sci. 22:. PubMed
  205. Xi W, et al. 2021. Stem Cell Res Ther. 167:12. PubMed
  206. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  207. Dawson CA, et al. 2021. Nature Protocols. 16(4):1907-1935. PubMed
  208. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  209. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  210. Tu WL, et al. 2018. Am J Pathol. 188:2688. PubMed
  211. Chiche A, et al. 2019. Breast Cancer Res. 21:13. PubMed
  212. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  213. Long JT, et al. 2022. Elife. 11:. PubMed
  214. Zhang Z, et al. 2021. Exp Dermatol. 30:102. PubMed
  215. Han Y, et al. 2022. Int J Biol Sci. 18:5653. PubMed
  216. Echevarría-Vargas IM, et al. 2018. EMBO Mol Med. 10:e8446. PubMed
  217. Shi R, et al. 2019. J Cancer. 10:367. PubMed
  218. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  219. Usmani SM et al. 2019. Cell host & microbe. 25(1):73-86 . PubMed
  220. Zasłona Z, et al. 2017. Am J Physiol Lung Cell Mol Physiol. 312:L855. PubMed
  221. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  222. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  223. Garcia-Bonilla L, et al. 2014. J Immunol. 193:2531. PubMed
  224. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  225. Wang L, et al. 2015. Cancer Immunol Res. 3: 1030-1041. PubMed
  226. Mueller A, et al. 2016. Nature. 540:276-279. PubMed
  227. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  228. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  229. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  230. Mori A, et al. 2021. Cells. :10. PubMed
  231. Dion-Albert L, et al. 2022. Nat Commun. 13:164. PubMed
  232. Saber M, et al. 2021. J Neurosci Res. 99:1136. PubMed
  233. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  234. Murdock BJ, et al. 2021. JCI Insight. 6:. PubMed
  235. Yang Y, et al. 2021. Cell Reports. 34(10):108822. PubMed
  236. Taya M, et al. 2020. Endocr Relat Cancer. 27:261. PubMed
  237. Cai B, et al. 2020. Cell Metabolism. 31(2):406-421.e7.. PubMed
  238. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  239. Toyama K, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1392. PubMed
  240. Qiao S, et al. 2019. J Neuroinflammation. 16:4. PubMed
  241. Zhang J, et al. 2022. Biomater Res. 26:44. PubMed
  242. Hoover AR, et al. 2022. Clin Transl Med. 12:e937. PubMed
  243. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  244. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  245. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  246. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  247. Elias S, et al. 2015. PLoS Biol. 13:1002142. PubMed
  248. Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed
  249. Zhang Y, et al. 2020. Cancer Res. 80:3345. PubMed
  250. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  251. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  252. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  253. Sroor HM, et al. 2019. Sci Rep. 9:20217. PubMed
  254. Chen PY, et al. 2019. Nat Metab. 0.675. PubMed
  255. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  256. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  257. Cai T, et al. 2022. Nat Commun. 13:2228. PubMed
  258. Kim KS, et al. 2022. JCI Insight. 7:. PubMed
  259. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  260. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  261. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  262. Piirainen S, et al. 2021. Glia. 69:2459. PubMed
  263. Arora S, et al. 2021. Med (N Y). 2:938. PubMed
  264. Li H, et al. 2022. iScience. 25:104481. PubMed
  265. Gopalakrishnapillai A, et al. 2021. Cancers (Basel). 13:. PubMed
  266. Cayre S, et al. 2020. Development. . PubMed
  267. Endo-Umeda K, et al. 2021. Sci Rep. 11:22595. PubMed
  268. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
  269. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  270. Saber M, et al. 2020. Eur J Neurosci. 52:2791. PubMed
  271. Vaas M, et al. 2016. J Cereb Blood Flow Metab. 10.1177/0271678X16676825. PubMed
  272. Wong J, et al. 2016. Sci Signal. 9: ra103. PubMed
  273. Yuan Z, et al. 2016. J Virol. 90: 7728 - 7739. PubMed
  274. Garcia-Bonilla L, et al. 2015. J Neurosci. 35: 14783 - 14793. PubMed
  275. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  276. Roberts L, et al. 2014. Infect Immun . 82:2504. PubMed
  277. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  278. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  279. Piotrowski AF, et al. 2018. Oncoimmunology. 7:e1445951. PubMed
  280. Sarshad AA, et al. 2018. Mol Cell. 71:1040. PubMed
  281. Kastenschmidt JM, et al. 2021. Cell Rep. 35:108997. PubMed
  282. Su M, et al. 2018. Immunol Cell Biol. 9:2448. PubMed
  283. Wunderlich CM, et al. 2018. Nat Commun. 9:1646. PubMed
  284. Peltzer N, et al. 2018. Nature. 557:112. PubMed
  285. Qu Y, et al. 2020. Cell Reports. 32(1):107873. PubMed
  286. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
  287. Koh BI, et al. 2020. Nat Commun. 3.143055556. PubMed
  288. Ren D, et al. 2020. Am J Cancer Res. 2851:10. PubMed
  289. Hu Y, et al. 2021. J Nanobiotechnology. 19:416. PubMed
  290. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  291. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  292. Liu C, et al. 2022. Nat Commun. 13:1989. PubMed
  293. Saber M, et al. 2021. J Neurotrauma. 38:2862. PubMed
  294. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  295. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  296. Deets KA, et al. 2021. Elife. 10:. PubMed
  297. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  298. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  299. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  300. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  301. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  302. Bravo JI, et al. 2021. STAR Protocols. 2(2):100406. PubMed
  303. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  304. Kabir AU, et al. 2018. JCI Insight. 3. PubMed
RRID
AB_312976 (BioLegend Cat. No. 103111)
AB_312977 (BioLegend Cat. No. 103112)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD45
Specificity Alt (DOES NOT SHOW ON TDS):
CD45
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account